Delisting riskPopularity #3,538
PDSB · NASDAQ · Biotechnology

PDS Biotechnology (PDSB)

Develops investigational immunotherapies for cancer and infectious diseases.

$0.8352
vs last close−0.07 (−8.22%)
  1. PDS Biotechnology (PDSB) Upgraded to Buy: Here's Why

    Zacks Investment Research